2026, Number 1
<< Back Next >>
Acta Ortop Mex 2026; 40 (1)
Comorbidity with increased risk for the development of secondary coxarthrosis in patients undergoing total reconstructive treatment
Paz-Zamora J, Gómez-Espíndola J, Díaz-De JB, Sánchez-Rodríguez J, Cortez-Ríos N, García-Delgadillo O, Castillo-García M, Torres-Olivo M
Language: Spanish
References: 17
Page: 3-8
PDF size: 293.55 Kb.
ABSTRACT
Introduction: primary coxarthrosis has no apparent cause, but secondary coxarthrosis is related to comorbidities such as rheumatic diseases. Reconstructive treatment by total hip arthroplasty is an alternative to treat secondary coxarthrosis. Although comorbidities associated with this condition have been investigated in the medical literature, little is known about which ones imply a higher risk for its development. Research question: what is the comorbidity with the highest risk for the development of secondary coxarthrosis in patients undergoing total hip reconstructive treatment?
Material and methods: descriptive, retrospective, non-experimental, cross-sectional study. Sample: clinical records of patients who underwent total hip arthroplasty for primary or secondary coxarthrosis. The method for calculating the sample was probabilistic by convenience. Statistical analysis included reports of frequencies, percentages, means and standard deviation, and bivariate analysis to identify relationships between variables. The odds ratio test was used to identify the comorbidity with the highest risk for the development of secondary coxarthrosis.
Results: of the total sample, 56 patients presented trauma; 23, hypertension; 16, rheumatic diseases. Relationships were found between the type of coxarthrosis and trauma (0.00), rheumatic diseases (0.000) and age (0.000). Only 41.2% of the patients had secondary coxarthrosis. The odds ratio test for secondary coxarthrosis yielded a value of 2.697 for trauma and 1.219 for rheumatic diseases.
Conclusions: trauma represents an increased risk for the development of secondary coxarthrosis and should be considered a significant risk factor.
REFERENCES
Murphy NJ, Eyles JP, Hunter DJ. Hip osteoarthritis: etiopathogenesis and implications for management. Adv Ther. 2016; 33(11): 1921-46.
Ostilla de Stefano RA, Jaramillo Thomas C. Artrosis de cadera. En: Martín Larrañaga N, ed. Hospital Universitario de Cruces. Manual de residentes de COT [Internet]. Bizkaia: SECOT. Capítulo 77. Disponible en: https://unitia.secot.es/web/manual_residente/CAPITULO%2077.pdf
Rachman T. Goniometría. Angewandte Chemie International Edition. 2018; 6(11): 951-2.
Verdugo-Meza RA, González-Castillo CJ, Gaona-Valle S, Salgado-Carbajal E, Rubí-Flores R. Claudicación, resultados funcionales y calidad de vida en artroplastía total de cadera primaria con abordaje anterolateral mínimamente invasivo. Acta Ortop Mex. 2019; 33(1): 8-12.
Foye PM, Stitik TP. Chapter 48: Hip osteoarthritis. In: Frontera WR, Silver JK, Rizzo TD, editors. Essentials of physical medicine and rehabilitation. musculoskeletal disorders, pain, and rehabilitation. 2nd ed. Philadelphia: Elsevier; 2008. p. 271-6. Available in: https://www.sciencedirect.com/science/article/pii/B978141604007150050X
Aguilera V, Araya F, García V, Reyes T, Vigas F, Flores D, et al. Artrosis de cadera: tus articulaciones también cumplen años [Internet]. Pontificia Universidad Católica de Chile; 2020.
Iñurrategui MC. Tratamiento conservador de la artrosis de cadera. Evid Actual Pract Ambul. 2021; 24(2): e002071.
Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, Goldring MB, et al. Osteoarthritis. Nat Rev Dis Primers. 2016; 2: 16072.
Oteo Álvaro A. Mecanismos etiopatogénicos de la artrosis. Rev Soc Esp Dolor [Internet]. 2021; 28(Suppl 1): 11-7. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1134-80462021000100011&lng=es
Chui M, Peralta D, Merizalde J, Cortez H, Dávila M, Velasco M, et al. Complicaciones y factores de riesgo en pacientes con prótesis total de cadera en un hospital de Guayaquil-Ecuador en el período 2010-2014. Rev Latinoam Hipertens. 2018; 13(4): 390-5.
Hoyos-Velasco LA, Palacio JC, Stangl WP, Chacón-Castillo CL, Palacio-Aragón V, Pulgarín JP. Factores de riesgo para complicaciones en artroplastia total de cadera. Rev Esp Cir Ortop Traumatol. 2025: S1888-4415(25)00035-9.
Wojcicki R, Pielak T, Erdmann J, Walus P, Ma?kowski B, Ohla J, et al. The Association between acetabulum fractures and subsequent coxarthrosis in a cohort of 77 patients-a retrospective analysis of predictors for secondary hip osteoarthritis. J Clin Med. 2023; 12(20): 6553.
Sarasa-Roca M, Angulo-Castaño MC, Gómez-Vallejo J, Torres-Campos A, Lasierra-SanRomán JM, Albareda-Albareda J. Artroplastia total de cadera primaria en fractura de acetábulo en el paciente anciano. Rev Esp Cir Ortop Traumatol. 2022; 66(1): 52-9.
Young BL, Watson SL, Perez JL, McGwin G, Singh JA, Ponce BA. Trends in joint replacement surgery in patients with rheumatoid arthritis. J Rheumatol. 2018; 45(2): 158-64.
Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021; 325(6): 568-78.
Zhang Y, Li X, Wang Y, Ge L, Pan F, Winzenberg T, et al. Association of knee and hip osteoarthritis with the risk of falls and fractures: a systematic review and meta-analysis. Arthritis Res Ther. 2023; 25(1): 184.
Jamsen E, Peltola M, Eskelinen A, Lehto MU. Comorbid diseases as predictors of survival of primary total hip and knee replacements: a nationwide register-based study of 96 754 operations on patients with primary osteoarthritis. Ann Rheum Dis. 2013; 72(12): 1975-82.
EVIDENCE LEVEL
II, estudio retrospectivo